CYP2U1
| cytochrome P450, family 2, subfamily U, polypeptide 1 | |
|---|---|
| Identifiers | |
| Symbol | CYP2U1 |
| Entrez | 113612 |
| HUGO | 20582 |
| OMIM | 610670 |
| RefSeq | NM_183075 |
| UniProt | Q7Z449 |
| Other data | |
| Locus | Chr. 4 q25 |
|
WikiDoc Resources for CYP2U1 |
|
Articles |
|---|
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on CYP2U1 at Clinical Trials.gov Clinical Trials on CYP2U1 at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on CYP2U1
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating CYP2U1 Risk calculators and risk factors for CYP2U1
|
|
Healthcare Provider Resources |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
CYP2U1 (cytochrome P450, family 2, subfamily U, polypeptide 1) is a protein which in humans is encoded by the CYP2U1 gene[1]
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids.[2] CYP2U1 metabolized arachidonic acid, docosahexaenoic acid (DHA), and other long chain fatty acids which suggests that CYP2U1 may play a role in brain and immune functions.[1]
References
- ↑ 1.0 1.1 Chuang SS, Helvig C, Taimi M, Ramshaw HA, Collop AH, Amad M, White JA, Petkovich M, Jones G, Korczak B (2004). "CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids". J. Biol. Chem. 279 (8): 6305–14. doi:10.1074/jbc.M311830200. PMID 14660610. Unknown parameter
|month=ignored (help) - ↑ "Entrez Gene: CYP2U1".
This article incorporates text from the United States National Library of Medicine, which is in the public domain.